Page last updated: 2024-08-26

bosentan anhydrous and Adult Premature Aging Syndrome

bosentan anhydrous has been researched along with Adult Premature Aging Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asano, Y; Hoashi, T; Kogure, A; Masuda, S; Mitsui, H; Miyagawa, T; Noda, S; Sato, S; Sugaya, M; Sugita, M; Tamaki, Z; Yamamoto, M	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Adult Premature Aging Syndrome

Article	Year
Bosentan: a novel therapy for leg ulcers in Werner syndrome. Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:2 Topics: Bosentan; Combined Modality Therapy; Debridement; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelin Receptor Antagonists; Follow-Up Studies; Humans; Leg Ulcer; Male; Middle Aged; Occlusive Dressings; Receptors, Endothelin; Severity of Illness Index; Sulfonamides; Treatment Outcome; Werner Syndrome; Wound Healing	2011

Article

Year

Bosentan: a novel therapy for leg ulcers in Werner syndrome.

Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:2

Topics: Bosentan; Combined Modality Therapy; Debridement; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelin Receptor Antagonists; Follow-Up Studies; Humans; Leg Ulcer; Male; Middle Aged; Occlusive Dressings; Receptors, Endothelin; Severity of Illness Index; Sulfonamides; Treatment Outcome; Werner Syndrome; Wound Healing

2011